NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE189084 Query DataSets for GSE189084
Status Public on Jul 13, 2022
Title MCF-7 Cell Derived Soluble Factors Define Growth of Vascular and Lymphatic Endothelial Cells: Modulatory Role of miR193a
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Angiogenesis and Lymphangiogenesis plays a key role in promoting tumor growth and breast cancer progression as well as metastasis. Active angiogenic process within the tumor tissue is known to promote cancer/tumor growth via nutrient supply, moreover, soluble molecules secreted by lymphatic endothelial cells (ECs) promotes tumor growth. Hence is feasible that paracrine factors generated by breast cancer cells play a role in regulating tumor neovascularization by lymphatic and vascular ECs. Here using cultured VECs and LECs assessed the paracrine impact of MCF-7 breast cancer derived soluble factors on LEC and VEC growth (cell number), gene expression (micro array) and angiogenic proteins (protein array). Moreover, we explored the modulatory actions of miR193 on LEC and VEC growth driven by MCF-7 derived conditioned medium (MCF7-CM). We demonstrate that MCF7-CM differentially modulates VEC and LEC growth, i.e. induces VEC growth and inhibits LEC growth. Moreover, the growth actions of MCF7-CM were accompanied with differential modulation VEC and LEC growth regulatory genes, that were further altered by miR193 a pretreatment of MCF7 cells. Our findings provide in-depth analysis of MCF7-CM altered genes relevant for angiogenesis and lymphogenesis. The fact that vascular capillaries support growth and lymphatic capillaries play a role counteracting cancer growth (kill cancer cells), together with our observation in VECs and LECs, suggests that MCF-7 breast cancer cells differentially modulate vascular and lymphatic growth to facilitate their survival and growth. Since miR193a abrogates the effects of MCF7-CM, it may be an effective therapeutic tool against breast cancer.
 
Overall design Proliferation, migration and angiogenesis arrays were performed to investigate the effects of the MCF7-CM on VECs and LECs.Microarray analysis was conducted to determine the genes involved in the differentilly effects on both endothelial cells. Additionally the cells were exposed to consitioned medium collected from MCF-7 cells pre-treated with and without E2 or pre-transfected with miR193a to determine possible effects of the sex hormone and estradiol sensitive miRs. CM (conditioned medium).
 
Contributor(s) Dubey RK, Azzarito G, Kurmann LM, Dubey RK
Citation(s) 35806196, 36230929, 36766731
Submission date Nov 18, 2021
Last update date Mar 02, 2023
Contact name Giovanna Azzarito
Organization name University Hospital Zurich
Department Reproductive endocrinology
Street address Wagistrasse 14
City Schlieren
ZIP/Postal code 8952
Country Switzerland
 
Platforms (1)
GPL23159 [Clariom_S_Human] Affymetrix Clariom S Assay, Human (Includes Pico Assay)
Samples (8)
GSM5694351 lymphatic endothelial cells+MCF-7 epithelial cells, mimic CTR
GSM5694352 lymphatic endothelial cells+MCF-7epithelial cells, miRNA193a
GSM5694353 vascular endothelial cells, CM by MCF-7 pre-transfected with mimic CTR
Relations
BioProject PRJNA781497

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE189084_HUVEC_CM_CTR_vs_miR193.xlsx 1.9 Mb (ftp)(http) XLSX
GSE189084_HUVEC_CM_vs._CTR.xlsx 1.9 Mb (ftp)(http) XLSX
GSE189084_LEC_CM_vs._CTR.xlsx 1.9 Mb (ftp)(http) XLSX
GSE189084_LECs_spheroids_miR193a_vs_CTR_.xlsx 1.9 Mb (ftp)(http) XLSX
GSE189084_RAW.tar 25.7 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap